145 related articles for article (PubMed ID: 36200383)
1. Vascular adhesion protein-1 (VAP-1) in vascular inflammatory diseases.
Danielli M; Thomas RC; Quinn LM; Tan BK
Vasa; 2022 Nov; 51(6):341-350. PubMed ID: 36200383
[No Abstract] [Full Text] [Related]
2. Vascular adhesion protein-1: Role in human pathology and application as a biomarker.
Pannecoeck R; Serruys D; Benmeridja L; Delanghe JR; van Geel N; Speeckaert R; Speeckaert MM
Crit Rev Clin Lab Sci; 2015; 52(6):284-300. PubMed ID: 26287391
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of semicarbazide-sensitive amine oxidase reduces atherosclerosis in apolipoprotein E-deficient mice.
Wang SH; Yu TY; Tsai FC; Weston CJ; Lin MS; Hung CS; Kao HL; Li YI; Solé M; Unzeta M; Chen YL; Chuang LM; Li HY
Transl Res; 2018 Jul; 197():12-31. PubMed ID: 29653075
[TBL] [Abstract][Full Text] [Related]
4. Vascular cell lines expressing SSAO/VAP-1: a new experimental tool to study its involvement in vascular diseases.
Solé M; Unzeta M
Biol Cell; 2011 Nov; 103(11):543-57. PubMed ID: 21819380
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase.
Salter-Cid LM; Wang E; O'Rourke AM; Miller A; Gao H; Huang L; Garcia A; Linnik MD
J Pharmacol Exp Ther; 2005 Nov; 315(2):553-62. PubMed ID: 16081681
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Semicarbazide-sensitive Amine Oxidase Reduces Atherosclerosis in Cholesterol-fed New Zealand White Rabbits.
Wang SH; Yu TY; Hung CS; Yang CY; Lin MS; Su CY; Chen YL; Kao HL; Chuang LM; Tsai FC; Li HY
Sci Rep; 2018 Jun; 8(1):9249. PubMed ID: 29915377
[TBL] [Abstract][Full Text] [Related]
7. Obesity of mice lacking VAP-1/SSAO by Aoc3 gene deletion is reproduced in mice expressing a mutated vascular adhesion protein-1 (VAP-1) devoid of amine oxidase activity.
Jargaud V; Bour S; Tercé F; Collet X; Valet P; Bouloumié A; Guillemot JC; Mauriège P; Jalkanen S; Stolen C; Salmi M; Smith DJ; Carpéné C
J Physiol Biochem; 2021 Feb; 77(1):141-154. PubMed ID: 32712883
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin blocks soluble SSAO/VAP-1 release in experimental models of cerebral ischemia: Possible benefits for stroke-induced inflammation control.
Sun P; Hernandez-Guillamón M; Campos-Martorell M; Simats A; Montaner J; Unzeta M; Solé M
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):542-553. PubMed ID: 29175057
[TBL] [Abstract][Full Text] [Related]
9. 68Ga-DOTA-Siglec-9--a new imaging tool to detect synovitis.
Virtanen H; Autio A; Siitonen R; Liljenbäck H; Saanijoki T; Lankinen P; Mäkilä J; Käkelä M; Teuho J; Savisto N; Jaakkola K; Jalkanen S; Roivainen A
Arthritis Res Ther; 2015 Nov; 17():308. PubMed ID: 26530096
[TBL] [Abstract][Full Text] [Related]
10. Vascular Adhesion Protein-1 (VAP-1)/Semicarbazide-Sensitive Amine Oxidase (SSAO): A Potential Therapeutic Target for Atherosclerotic Cardiovascular Diseases.
Li H; Du S; Niu P; Gu X; Wang J; Zhao Y
Front Pharmacol; 2021; 12():679707. PubMed ID: 34322017
[TBL] [Abstract][Full Text] [Related]
11. Semicarbazide-Sensitive Amine Oxidase (SSAO) and Lysyl Oxidase (LOX) Association in Rat Aortic Vascular Smooth Muscle Cells.
Manasieva V; Thakur S; Lione LA; Patel J; Baydoun A; Skamarauskas J
Biomolecules; 2022 Oct; 12(11):. PubMed ID: 36358914
[TBL] [Abstract][Full Text] [Related]
12. Vascular adhesion protein-1 in human ischaemic stroke.
Airas L; Lindsberg PJ; Karjalainen-Lindsberg ML; Mononen I; Kotisaari K; Smith DJ; Jalkanen S
Neuropathol Appl Neurobiol; 2008 Aug; 34(4):394-402. PubMed ID: 18005095
[TBL] [Abstract][Full Text] [Related]
13. SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer's Disease.
Unzeta M; Hernàndez-Guillamon M; Sun P; Solé M
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805974
[TBL] [Abstract][Full Text] [Related]
14. Soluble Vascular Adhesion Protein-1 Mediates Spermine Oxidation as Semicarbazide-Sensitive Amine Oxidase: Possible Role in Proliferative Diabetic Retinopathy.
Murata M; Noda K; Kawasaki A; Yoshida S; Dong Y; Saito M; Dong Z; Ando R; Mori S; Saito W; Kanda A; Ishida S
Curr Eye Res; 2017 Dec; 42(12):1674-1683. PubMed ID: 28937866
[TBL] [Abstract][Full Text] [Related]
15. Origins of serum semicarbazide-sensitive amine oxidase.
Stolen CM; Yegutkin GG; Kurkijärvi R; Bono P; Alitalo K; Jalkanen S
Circ Res; 2004 Jul; 95(1):50-7. PubMed ID: 15178639
[TBL] [Abstract][Full Text] [Related]
16. Involvement of SSAO/VAP-1 in oxygen-glucose deprivation-mediated damage using the endothelial hSSAO/VAP-1-expressing cells as experimental model of cerebral ischemia.
Sun P; Solé M; Unzeta M
Cerebrovasc Dis; 2014; 37(3):171-80. PubMed ID: 24503888
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 reduces lipopolysaccharide-induced neuroinflammation.
Becchi S; Buson A; Foot J; Jarolimek W; Balleine BW
Br J Pharmacol; 2017 Jul; 174(14):2302-2317. PubMed ID: 28437839
[TBL] [Abstract][Full Text] [Related]
18. PXS-4681A, a potent and selective mechanism-based inhibitor of SSAO/VAP-1 with anti-inflammatory effects in vivo.
Foot JS; Yow TT; Schilter H; Buson A; Deodhar M; Findlay AD; Guo L; McDonald IA; Turner CI; Zhou W; Jarolimek W
J Pharmacol Exp Ther; 2013 Nov; 347(2):365-74. PubMed ID: 23943052
[TBL] [Abstract][Full Text] [Related]
19. Blood-brain barrier dysfunction underlying Alzheimer's disease is induced by an SSAO/VAP-1-dependent cerebrovascular activation with enhanced Aβ deposition.
Solé M; Esteban-Lopez M; Taltavull B; Fábregas C; Fadó R; Casals N; Rodríguez-Álvarez J; Miñano-Molina AJ; Unzeta M
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2189-2202. PubMed ID: 31047972
[TBL] [Abstract][Full Text] [Related]
20. Glitazones inhibit human monoamine oxidase but their anti-inflammatory actions are not mediated by VAP-1/semicarbazide-sensitive amine oxidase inhibition.
Carpéné C; Bizou M; Tréguer K; Hasnaoui M; Grès S
J Physiol Biochem; 2015 Sep; 71(3):487-96. PubMed ID: 25572340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]